Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma Of Esophagus

Explore clinical trials studying Adenocarcinoma Of Esophagus. Study availability and eligibility vary by location and protocol.

254 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma Of Esophagus trial results

Completed

S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach

NCT00004233

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 97 locations
View Trial Details
Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

NCT00054873

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • ACRC/Arizona Clinical Research Center Tucson, Arizona, United States
  • Glendale Memorial Hospital Glendale, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

NCT05476796

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +12 more
Locations
  • Clinique de l'Europe Amiens, France
  • Hopital Privé Arras Les Bonnettes Arras, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Beauvais Beauvais, France
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

NCT06628310

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, +1 more
Locations
  • City of Hope National Medical Center /ID# 268690 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 272630 Irvine, California, United States
  • UCLA - Santa Monica /ID# 270024 Santa Monica, California, United States
  • AdventHealth Orlando /ID# 268561 Orlando, Florida, United States
View all 49 locations
View Trial Details

Related conditions